The Financial Times US Healthcare & Life Sciences Summit featured a panel on drug pricing featuring ICER’s Chief Operating Officer Sarah Emond.

Also on the panel were: Peter Bach (Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center), Jonathan Emms (Senior Vice President, Global Health and Value, Pfizer), Jeff Myers (President and CEO, Medicaid Health Plans of America), and Leonard Schleifer(President and CEO, Regeneron).  The panel was moderated by Andrew Ward (Pharmaceuticals Correspondent, Financial Times).